Question 1

What is the catalog number for VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued?

Accepted Answer

The catalog number for VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued is V2124-28-AP.

Question 2

What sizes are available for VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued?

Accepted Answer

VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued is available in the following size(s): 200 µL.

Question 3

Is VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued in stock?

Accepted Answer

VILIP3, NT (Visinin-like Protein 3, Calcium-binding Protein BDR-1, HLP2, Hippocalcin-like Protein 1, HPCAL1, BDR1) (AP) discontinued

Selected Variant

V2124-28-AP

Size: 200 µL

Product Specifications

Clonality

Pab

Question 4

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Question 5

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 6

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.